Abstract:Stress granules (SGs), hallmarks of the cellular adaptation to stress, promote survival, conserve cellular energy, and are fully dissolved upon the cessation of stress treatment. Different stresses can initiate the assembly of SGs, but arsenite and heat are the best studied of these stresses. The composition of SGs and posttranslational modifications of SG proteins differ depending on the type and severity of the stress insult, methodology used, cell line, and presence of overexpressed and tagged proteins. A group of 18 proteins showing differential localization to SGs in heat‐ and arsenite‐stressed mammalian cell lines is described. Upon severe and prolonged stress, physiological SGs transform into more solid protein aggregates that are no longer reversible and do not contain mRNA. Similar pathological inclusions are hallmarks of neurodegenerative diseases. SGs induced by heat stress are less dynamic than SGs induced by arsenite and contain a set of unique proteins and linkage‐specific polyubiquitinated proteins. The same types of ubiquitin linkages have been found to contribute to the development of neurodegenerative disorders such as Parkinson disease, Alzheimer disease, and amyotrophic lateral sclerosis (ALS). We propose heat stress‐induced SGs as a possible model of an intermediate stage along the transition from dynamic, fully reversible arsenite stress‐induced SGs toward aberrant SGs, the hallmark of neurodegenerative diseases. Stress‐ and methodology‐specific differences in the compositions of SGs and the transition of SGs to aberrant protein aggregates are discussed.This article is categorized under:RNA in Disease and Development > RNA in DiseaseRNA Interactions with Proteins and Other Molecules > RNA–Protein ComplexesRNA Export and Localization > RNA Localization

Targeting stress granules: A novel therapeutic strategy for human diseases

Friend or Foe: the Role of Stress Granule in Neurodegenerative Disease

Stress Granule: A Promising Target For Cancer Treatment

Stress granules: potential therapeutic targets for infectious and inflammatory diseases

Stress-specific differences in assembly and composition of stress granules and related foci

Stress Granule Formation and Its Biological Functions

Response to stress in biological disorders: Implications of stress granule assembly and function

Molecular structure of stress granules and their role in the eukaryotic cell

The involvement of stress granules in aging and aging‐associated diseases

Targeting the NTF2-like domain of G3BP1: Novel modulators of intracellular granule dynamics

Stress granules in cancer: Adaptive dynamics and therapeutic implications

Role of stress granules in tumorigenesis and cancer therapy

A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules

Stress granules in the spinal muscular atrophy and amyotrophic lateral sclerosis: The correlation and promising therapy

Changing faces of stress: Impact of heat and arsenite treatment on the composition of stress granules

Stress granules and neurodegeneration

Aberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis

Understanding the Roles of Stress Granule During Chemotherapy for Patients with Malignant Tumors.

Multiple Functions of Stress Granules in Viral Infection at a Glance

Stress Granules in Atherosclerosis: Insights and Therapeutic Opportunities

Tracking Stress Granule Dynamics in Live Cells and in Vivo with a Small Molecule